Similar articles

• Etoposide in Wegener's granulomatosis.

  Morton SJ, Lanyon PC, Powell RJ. Morton SJ, et al. Rheumatology (Oxford). 2000 Jul;39(7):810-1. doi: 10.1093/rheumatology/39.7.810. Rheumatology (Oxford). 2000. PMID: 10908706 No abstract available.
• Response of cyclophosphamide-resistant Wegener's granulomatosis to etoposide.

  D'Cruz D, Payne H, Timothy A, Hughes GR. D'Cruz D, et al. Lancet. 1992 Aug 15;340(8816):425-6. doi: 10.1016/0140-6736(92)91505-3. Lancet. 1992. PMID: 1353574 No abstract available.
• Etoposide: sometimes the drug of choice in Wegener's granulomatosis?

  Pedersen RS, Jensen DM. Pedersen RS, et al. Nephrol Dial Transplant. 1995;10(9):1759-61. Nephrol Dial Transplant. 1995. PMID: 8559502 No abstract available.
• A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.

  Quan MV, Frankel SK, Maleki-Fischbach M, Tan LD. Quan MV, et al. BMC Pulm Med. 2018 Nov 29;18(1):181. doi: 10.1186/s12890-018-0733-2. BMC Pulm Med. 2018. PMID: 30497438 Free PMC article. Review.
• [Wegener's disease and central diabetes insipidus].

  Berthier S, Gil H, Bonneville JF, Magy N, De Wazieres B, Mallet H, Dupond JL. Berthier S, et al. Ann Endocrinol (Paris). 2000 Dec;61(6):531-537. Ann Endocrinol (Paris). 2000. PMID: 11148328 Review. French.